Boosting brain protein levels may slow decline from Alzheimer’s
A study found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of a specific protein in the brain.
A study found that new monoclonal antibody drugs for Alzheimer’s may slow cognitive impairment through boosting levels of a specific protein in the brain.
Findings from a new study suggest that older people with mild cognitive impairment who engage in high levels of activities such as word games and
Researchers have published a novel study exploring the effects of delayed feedback on learning in individuals with moderate-to-severe traumatic brain injury. The goal of this
Researchers are using works by Johann Sebastian Bach, along with MEG and MRI scans, to investigate how the brain compensates for age-related changes.
Research discovered a unique and promising avenue for diagnosing Alzheimer’s disease (AD) earlier — by analyzing AD biomarkers in blood — so that the impacts